406 related articles for article (PubMed ID: 35771136)
21. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
22. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma.
Chen B; Yang Z; Lang Z; Tao Q; Zhang R; Zhan Y; Xu X; Zhu K; Zheng J; Yu Z; Yu S
BMC Cancer; 2022 Aug; 22(1):867. PubMed ID: 35941582
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
Front Genet; 2022; 13():929035. PubMed ID: 36081998
[No Abstract] [Full Text] [Related]
24. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
25. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
26. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
27. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma.
Lin W; Tan ZY; Fang XC
SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541
[TBL] [Abstract][Full Text] [Related]
28. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
29. Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma.
Lu J; Yang P; Yu L; Xie N; Wu Y; Li B
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238181
[TBL] [Abstract][Full Text] [Related]
30. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of Molecular Clusters and Prognostic Signature Based on m7G-related LncRNAs in Esophageal Squamous Cell Carcinoma.
Zhao F; Dong Z; Li Y; Liu S; Guo P; Zhang D; Li S
Front Oncol; 2022; 12():893186. PubMed ID: 35912250
[TBL] [Abstract][Full Text] [Related]
33. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
Li Y; Zhao K; Wu R; Wang J; Wang Q; Xiong Q; Xie F; Lei H; Feng P
J Gastrointest Oncol; 2023 Jun; 14(3):1392-1411. PubMed ID: 37435203
[TBL] [Abstract][Full Text] [Related]
34. Identification and Validation of an m7G-Related lncRNAs Signature for Prognostic Prediction and Immune Function Analysis in Endometrial Cancer.
Sun J; Li L; Chen H; Gan L; Guo X; Sun J
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893039
[TBL] [Abstract][Full Text] [Related]
35. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
36. The m7G-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumour Immune Infiltration in Colon Cancer.
Liu L; Wu Y; Chen W; Li Y; Yu J; Zhang G; Fu P; Huang L; Xiong J; Jie Z
Front Genet; 2022; 13():892589. PubMed ID: 35846130
[TBL] [Abstract][Full Text] [Related]
37. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
38. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
Yang S; Xu J; Zeng X
Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
[TBL] [Abstract][Full Text] [Related]
39. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
40. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]